Neural mechanisms underlying morphine withdrawal in addicted patients: a review

سال انتشار: 1394
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 346

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_RCM-2-3_010

تاریخ نمایه سازی: 2 دی 1398

چکیده مقاله:

Morphine is one of the most potent alkaloid in opium, which has substantial medical uses and needs and it is the first active principle purified from herbal source. Morphine has commonly been used for relief of moderate to severe pain as it acts directly on the central nervous system; nonetheless, its chronic abuse increases tolerance and physical dependence, which is commonly known as opiate addiction. Morphine withdrawal syndrome is physiological and behavioral symptoms that stem from prolonged exposure to morphine. A majority of brain regions are hypofunctional over prolonged abstinence and acute morphine withdrawal. Furthermore, several neural mechanisms are likely to contribute to morphine withdrawal. The present review summarizes the literature pertaining to neural mechanisms underlying morphine withdrawal. Despite the fact that morphine withdrawal is a complex process, it is suggested that neural mechanisms play key roles in morphine withdrawal.

نویسندگان

Nima Babhadiashar

Iranian National Center for Addiction Studies (INCAS), Iranian Institute for Reduction of High-risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.

Golnaz Vaseghi

Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Mahmoud Rafieian-Kopaei

Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran

Sasan Andalib

Neurosciences Research Center, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Luch A. Molecular and Environmental Toxicology. Berlin: Springer; 2009. ...
  • Poeaknapo C, Schmidt J, Brandsch M, et al. Endogenous formation ...
  • Gutstein H, Akil H, Lazo J, et al. Goodman and ...
  • Way W, Field H, Schumacher M. Opiod Analgesics and Antagonists. ...
  • Martin WR, Eades C, Thompson J, et al. The effects ...
  • van Rijn RM, DeFriel JN, Whistler JL. Pharmacological traits of ...
  • Giri AK, Hruby VJ. Investigational peptide and peptidomimetic μ and ...
  • Audigier Y, Attali B, Mazarguil H, et al. Characterization of ...
  • McEvoy G. Morphine Sulfate. AHFS drug information, Bethesda. American Society ...
  • Meine TJ, Roe MT, Chen AY, et al. Association of ...
  • Freye E, Latasch L. [Development of opioid tolerance--molecular mechanisms and ...
  • Stein C. Opioids, sensory systems and chronic pain. Eur J ...
  • Bodnar RJ. Endogenous opiates and behavior: 2008. Peptides. 2009;30:2432-2479. ...
  • Ahmadiasl N, Alipour MR, Andalib S, et al. Effect of ...
  • Guarna M, Ghelardini C, Galeotti N, et al. Effects of ...
  • Williams JT, Ingram SL, Henderson G, et al. Regulation of ...
  • Martín F, Laorden ML, Milanés M. Morphine withdrawal regulates phosphorylation ...
  • Laorden ML, Fuertes G, González-Cuello A, et al. Changes in ...
  • Roshanpour M, Ghasemi M, Riazi K, et al. Tolerance to ...
  • Koch T, Höllt V. Role of receptor internalization in opioid ...
  • Faris PL, Komisaruk BR, Watkins LR, et al. Evidence for ...
  • Mirzaii-Dizgah I, Ojaghi R, Sadeghipour-Roodsari HR, et al. Attenuation of ...
  • Feng P, Meissler JJ, Adler MW, et al. Morphine withdrawal ...
  • Miller L. Neuropsychological assessment substance abusers: review and recommendations. J ...
  • O’Brien C. Drug addiction and drug abuse. In: Brunton L, ...
  • Dalrymple T. Romancing opiates: Pharmacological lies and the addiction bureaucracy: ...
  • Krystal JH, Woods SW, Kosten TR, et al. Opiate dependence ...
  • Roozendaal B. Stress and memory: opposing effects of glucocorticoids on ...
  • Rabbani M, Hajhashemi V, Mesripour A. Increase in brain corticosterone ...
  • Mesripour A, Hajhashemi V, Rabbani M. Metyrapone and mifepristone reverse ...
  • Morley JE. The endocrinology of the opiates and opioid peptides. ...
  • McGaugh JL, Roozendaal B. Role of adrenal stress hormones in ...
  • Gong Y-x, Shou W-t, Feng B, et al. Ameliorating effect ...
  • Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch ...
  • Reul JM. Making memories of stressful events: a journey along ...
  • Ueno K, Maeda T, Kiguchi N, et al. Availability of ...
  • Varamini P, Blanchfield JT, Toth I. Endomorphin derivatives with improved ...
  • Masoudian N, Masoudian N, Rashidy Pour A, et al. Evaluation ...
  • Luine V, Martinez C, Villegas M, et al. Restraint stress ...
  • Vaseghi G, Rabbani M, Hajhashemi V. The effect of nimodipine ...
  • Vitcheva V, Mitcheva M. Effects of nifedipine on behavioral and ...
  • Esmaeili-Mahani S, Fathi Y, Motamedi F, et al. L-type calcium ...
  • Karst H, Nair S, Velzing E, et al. Glucocorticoids alter ...
  • Vaseghi G, Rabbani M, Hajhashemi V. The CB1 receptor antagonist, ...
  • Rabbani M, Vaseghi G, Hajhashemi V. AM281, Cannabinoid Antagonist/Inverse agonist, ...
  • O’Leary DS, Block RI, Koeppel JA, et al. Effects of ...
  • Yamamoto T, Takada K. Role of cannabinoid receptor in the ...
  • Yamamoto T, Anggadiredja K, Hiranita T. New perspectives in the ...
  • Maguire DR, Yang W, France CP. Interactions between μ-opioid receptor ...
  • Lopez-Moreno J, Lopez-Jimenez A, Gorriti M, et al. Functional interactions ...
  • Yuan WX, Heng LJ, Ma J, et al. Increased expression ...
  • Manwell LA, Satvat E, Lang ST, et al. FAAH inhibitor, ...
  • Kaplan GB, Coyle TS. Adenosine kinase inhibitors attenuate opiate withdrawal ...
  • Jang S, Kim H, Kim D, et al. Attenuation of ...
  • Raghavendra V, Tanga FY, DeLeo JA. Attenuation of morphine tolerance, ...
  • Ayromlou H, Masoudian N, Ahmadi-Asl N, et al. Evaluation of ...
  • Riahi E, Mirzaii-Dizgah I, Karimian SM, et al. Attenuation of ...
  • Mirzaii-Dizgah I, Karimian SM, Hajimashhadi Z, et al. Attenuation of ...
  • Bexis S, Ong J, White J. Attenuation of morphine withdrawal ...
  • Leal MB, Michelin K, Souza DO, et al. Ibogaine attenuation ...
  • Dunbar SA, Karamian I, Zhang J. Ketorolac prevents recurrent withdrawal ...
  • Beninger RJ. The role of dopamine in locomotor activity and ...
  • Bardo MT. Neuropharmacological mechanisms of drug reward: beyond dopamine in ...
  • Pettit HO, Justice JB. Dopamine in the nucleus accumbens during ...
  • Acquas E, Chiara G. Depression of mesolimbic dopamine transmission and ...
  • Aghajanian GK. Tolerance of locus coeruleus neurones to morphine and ...
  • Maldonado R, Stinus L, Gold L, et al. Role of ...
  • Koob GF, Wall T, Bloom FE. Nucleus accumbens as a ...
  • Stinus L, Le Moal M, Koob GF. Nucleus accumbens and ...
  • Chartoff EH, Mague SD, Barhight MF, et al. Behavioral and ...
  • نمایش کامل مراجع